SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations of 713.03 thousand shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations · last filed 2025-08-13
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-06-30 was 713.03K shares.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, expirations for the quarter ending 2025-03-31 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations 6 month |
|---|---|---|
| 2025-06-30 | 713.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 713.03K shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |